Sign in

CIK 0000748592 · Non-accelerated filer<br>Smaller reporting company

Ernexa Therapeutics Inc.

Sign in to watch
Ticker
ERNA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
311103425
Phone
(617) 798-6700
Business address
1035 CAMBRIDGE STREET, SUITE 18A, CAMBRIDGE, MA, 02141
Former names
Eterna Therapeutics Inc., Brooklyn ImmunoTherapeutics, Inc., NTN BUZZTIME INC, NTN COMMUNICATIONS INC

Securities

  • ERNA Common Stock Nasdaq
  • ERNAW Warrants Nasdaq
  1. 8-K Event Material agreement
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. SC 13D/A Stake Beneficial Ownership Report
  5. 4 Open-market buy 10% owner bought 25,000 shares at $0.24 ($5,948)
  6. 4 Open-market buy 10% owner bought 25,000 shares at $0.27 ($6,783)
  7. 10-K Report Annual Report
  8. 4 Open-market buy 10% owner bought 106,700 shares at an average $0.22 ($23,338)
  9. 8-K Event Results of operations
  10. SC 13D/A Stake Beneficial Ownership Report
  11. 4 Open-market buy 10% owner bought 100,160 shares at $0.22 ($22,266)
  12. 8-K Event Executive or director change
  13. 4 Derivatives Options or other derivatives
  14. 3 Insider Initial Statement of Ownership
  15. 8-K Event Executive or director change
  16. 4 Open-market buy 10% owner bought 27,700 shares at $0.22 ($6,158)
  17. 4/A Open-market buy 10% owner bought 644,500 shares at an average $0.13 ($83,368)
  18. 8-K Event Executive or director change
  19. 8-K Event Executive or director change
  20. 4 Derivatives Options or other derivatives

Page 55 of 77 · 1,525 filings